Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Neurologist ; 25(5): 122-125, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32925482

ABSTRACT

BACKGROUND AND PURPOSE: Elevated high-sensitivity C-reactive protein (hs-CRP) has been suggested as a risk factor for ischemic stroke. However, the predictive value of hs-CRP for long-term outcomes is poorly defined. Therefore, we conducted this study to evaluate whether change in hs-CRP level plays a role in the prognostic value of long-term functional disability. METHODS: We studied 263 patients with acute ischemic stroke and 104 healthy controls (67.5±11.26 and 68.17±11.21 y, respectively). hs-CRP was measured on admission and on the seventh day of hospitalization. The patients were classified into 2 groups on the basis of difference in hs-CRP level from admission to the seventh day of hospitalization (group 1, hs-CRP on admission>the seventh hospital day; group 2, hs-CRP on admission

Subject(s)
C-Reactive Protein/metabolism , Ischemic Stroke/blood , Ischemic Stroke/diagnosis , Outcome Assessment, Health Care , Aged , Aged, 80 and over , Female , Follow-Up Studies , Hospitalization , Humans , Ischemic Stroke/therapy , Male , Middle Aged , Time Factors
2.
Muscle Nerve ; 59(5): 544-548, 2019 05.
Article in English | MEDLINE | ID: mdl-30488463

ABSTRACT

INTRODUCTION: Herein we report our experience with the repetitive nerve stimulation (RNS) test in myasthenia gravis (MG) crisis. METHODS: The various parameters of the RNS tests in 26 patients with MG crisis were analyzed. RESULTS: In 18 (69%) patients, MG crisis is the first manifestation of MG. RNS tests were abnormal in 24 (92%) patients by decrement at low-rate stimulation in any of 4 tested muscles. Three patterns of abnormality were found: MG pattern (decrement at low-rate stimulation) in 23 patients; Lambert-Eaton myasthenic syndrome pattern in 1 patient; and cholinergic crisis pattern in 1 patient. DISCUSSION: During MG crisis, the RNS test can serve as a rapid and sensitive diagnostic tool for MG in a majority of patients. Muscle Nerve 59:544-544, 2019.


Subject(s)
Action Potentials , Lambert-Eaton Myasthenic Syndrome/diagnosis , Myasthenia Gravis/diagnosis , Adult , Aged , Diagnostic Techniques, Neurological , Disease Progression , Electric Stimulation/methods , Electromyography/methods , Female , Humans , Lambert-Eaton Myasthenic Syndrome/physiopathology , Male , Middle Aged , Myasthenia Gravis/physiopathology , Peripheral Nerves
3.
Arch Gerontol Geriatr ; 63: 55-8, 2016.
Article in English | MEDLINE | ID: mdl-26631627

ABSTRACT

BACKGROUND: The association between cerebrovascular atherosclerosis and Alzheimer's disease (AD) has been examined in many cross-sectional studies; however, there are few data regarding the role of cerebrovascular atherosclerosis on the longitudinal course of cognitive decline in AD. The aim of this study was to examine the progression of cognitive function in AD patients with cerebrovascular atherosclerosis compared to those without atherosclerosis over a two-year period. METHODS: Forty-seven AD patients with cerebrovascular atherosclerosis and 81 AD patients without atherosclerosis were assessed for cognitive function at the time of diagnosis and again at follow-up after two years. The cognitive functions were evaluated by neuropsychological tests including mini-mental state examination (MMSE) and clinical dementia scale (CDR). RESULTS: Repeated-measures multivariate analyses showed that there was a significant group-by-time interactions for the temporal changes of the MMSE and CDR between the two groups. The group-by-time interactions remained significant when the atherosclerotic patients were sub-classified into either an extracranial stenosis (EC) group or an intracranial stenosis(IC) group. Comparing either the EC or IC group with the non-atherosclerosis group, there were no main effects by time or group alone, but there were significant group-by-time interactions for the MMSE and CDR. CONCLUSIONS: Cognitive function worsened more in terms of progressive impairment in AD patients with cerebrovascular atherosclerosis compared to AD patients without cerebrovascular atherosclerosis, regardless of whether the atherosclerosis was extracranial or intracranial.


Subject(s)
Alzheimer Disease/complications , Atherosclerosis/complications , Cognition Disorders/physiopathology , Cognition/physiology , Neuropsychological Tests , Aged , Aged, 80 and over , Alzheimer Disease/physiopathology , Alzheimer Disease/psychology , Atherosclerosis/physiopathology , Cross-Sectional Studies , Dementia/diagnosis , Disease Progression , Female , Humans , Male , Middle Aged , Multivariate Analysis
4.
J Korean Med Sci ; 30(7): 974-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26130963

ABSTRACT

The frequency and extent of the existence of a familial suicide prevention plan may differ across cultures. The aim of this work was, therefore, to determine how common it was for families to develop a suicide prevention plan and to compare the main measures used by families with and without such a plan, after an attempt to commit suicide was made by a member of a family living in a rural area of Korea. On the basis of the presence or absence of a familial suicide prevention plan, we compared 50 recruited families that were divided into 2 groups, with Group A (31 families) employing a familial suicide prevention plan after a suicide attempt by a family member, and Group B (19 families) not doing so. The strategy that was employed most frequently to prevent a reoccurrence among both populations was promoting communication among family members, followed by seeking psychological counseling and/or psychiatric treatment. Contrary to our expectation, the economic burden from medical treatment after a suicide attempt did not influence the establishment of a familial suicide prevention plan. It is a pressing social issue that 38% (19 of 50) of families in this study did not employ a familial suicide prevention plan, even after a family member had attempted suicide. Regional suicide prevention centers and/or health authorities should pay particular attention to these patients and their families.


Subject(s)
Hospitalization/economics , Patient Care Planning/statistics & numerical data , Suicide, Attempted/prevention & control , Family , Female , Humans , Male , Middle Aged , Republic of Korea , Risk Factors , Surveys and Questionnaires
6.
Diabetes Metab J ; 35(5): 551-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22111048

ABSTRACT

BACKGROUND: The role of glycated hemoglobin (HbA1c) in the prediction of ischemic stroke in non-diabetic subjects is not clear. We performed a study to analyze the role of HbA1c in the risk prediction of ischemic stroke in non-diabetic Korean males adult. METHODS: A total of 307 non-diabetic male patients with ischemic stroke were enrolled, and 253 age-matched control subjects without a history of diabetes, hypertension, or cardiovascular disease were selected from a Health Check-up database. Anthropometric measurement data, fasting glucose level, lipid profile, and HbA1c level were available for all subjects. Associations of the variables and the presence or absence of ischemic stroke were analyzed. RESULTS: The ischemic stroke patient group had significantly higher HbA1c levels (5.8±0.5% vs. 5.5±0.5%, P<0.01) and mean systolic and diastolic blood pressure compared with the control group. Among the variables, smoking, low high density lipoprotein cholesterol, systolic blood pressure, and HbA1c were the significant determinants for ischemic stroke. The highest quartile of HbA1c showed a 9.6-fold increased odds ratio for ischemic stroke compared with the lowest quartile of HbA1c (odds ratio, 9.596; 95% confidence interval, 3.859 to 23.863, P<0.01). The proportion of ischemic stroke patients showed a significant trend for increment as the deciles of HbA1c increased (P for trend <0.01). CONCLUSION: Higher HbA1c indicated a significantly increased risk for ischemic stroke after adjusting for other confounding variables in non-diabetic Korean adult males. HbA1c might have significance in predicting the risk for ischemic stroke even in the non-diabetic range.

7.
J Clin Neurol ; 7(1): 43-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21519527

ABSTRACT

BACKGROUND: Lambert-Eaton myasthenic syndrome is well known to be a classical paraneoplastic syndrome of small cell lung carcinoma (SCLC). Three cases of seronegative myasthenia gravis (MG) and SCLC were previously reported. CASE REPORT: A 65-year-old man developed a severe progressive respiratory failure with clinical features of MG. Tests showed a decremental response in the repetitive nerve stimulation test, abnormal single-fiber electromyography, and positive acetylcholine receptor antibody. SCLC was confirmed by the lung biopsy. CONCLUSIONS: This case represents the first case of seropositive MG and SCLC.

8.
Korean J Intern Med ; 25(4): 422-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21179281

ABSTRACT

BACKGROUND/AIMS: Many patients with acute paraquat (PQ) intoxication die even at low PQ concentrations, whereas others with similar concentrations recover. Therefore, it is possible that individual differences in antioxidant capacity are responsible for the variable clinical outcome in patients with acute PQ intoxication. METHODS: We investigated whether there was a relationship between the genetic polymorphisms of SOD (V16A), catalase (C262T), and GPX1 (C593T) in 62 patients with acute PQ intoxication and the clinical outcomes of these patients. RESULTS: The frequency of the Mn-SOD V/V, V/A, and A/A genotypes were 56.3, 43.5, and 0% in survivors and 86.9, 13.1, and 0% in non-survivors (p > 0.05). The GPX1 C/C, C/T, and T/T genotypes were present in 100, 0, and 0% of all subjects. The catalase C/C, C/T, and T/T genotypes were present in 100, 0, and 0% of survivors, and in 82.6, 17.4, and 0% of non-survivors. Neither erythrocyte SOD activity nor catalase activity were significantly different between survivors and non-survivors. CONCLUSIONS: No association was found between clinical outcome of acute PQ intoxication and the genetic polymorphism of GPX1 (C593T) or the genetic polymorphisms or enzyme activity of superoxide dismutase (V16A) or catalase (C262T).


Subject(s)
Catalase/genetics , Paraquat/poisoning , Polymorphism, Genetic , Superoxide Dismutase/genetics , Acute Disease , Adult , Aged , Female , Genotype , Glutathione Peroxidase/genetics , Humans , Male , Middle Aged , Poisoning/mortality , Glutathione Peroxidase GPX1
9.
J Clin Neurol ; 6(2): 99-101, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20607049

ABSTRACT

BACKGROUND: Under certain conditions, exertional headaches may reflect coronary ischemia. CASE REPORT: A 44-year-old woman developed intermittent exercise-induced headaches with chest tightness over a period of 10 months. Cardiac catheterization followed by acetylcholine provocation demonstrated a right coronary artery spasm with chest tightness, headache, and ischemic effect of continuous electrocardiography changes. The patient's headache disappeared following intra-arterial nitroglycerine injection. CONCLUSIONS: A coronary angiogram with provocation study revealed variant angina and cardiac cephalalgia, as per the International Classification of Headache Disorders (code 10.6). We report herein a patient with cardiac cephalalgia that manifested as reversible coronary vasospasm following an acetylcholine provocation test.

10.
Alzheimer Dis Assoc Disord ; 24(3): 227-33, 2010.
Article in English | MEDLINE | ID: mdl-20473133

ABSTRACT

BACKGROUND: White matter hyperintensities (WMH) have been associated with cognitive impairment in elderly persons and in patients with Alzheimer disease. However, the role of WMH in Parkinson disease (PD) dementia remains to be elucidated. METHODS: The cohort for this study comprised 71 consecutive patients with PD, all of whom completed a clinical assessment, neuropsychologic investigation, and magnetic resonance imaging of brain. WMH were rated using the semiquantitative visual rating system proposed by Scheltens et al. RESULTS: The PD dementia group had significantly more WMH than the PD without dementia group in the evaluated brain regions except for the infratentorial area. The WMH showed a significant correlation with age, Unified Parkinson's Disease Rating Scale, Mini-Mental State Examination, sum of the box of Clinical Dementia Rating, and many of the cognitive domains. The linear regression model showed that the WMH was independently associated with cognitive impairment in patients with PD, regardless of age, sex, duration or severity of PD symptoms, and vascular risk factors. CONCLUSIONS: These findings confirm that WMH might be associated with cognitive decline in patients with PD, regardless of age, sex, education status, duration or severity of PD symptoms, and vascular risk factors. This result suggests that other nonvascular factors contribute to the progression of dementia in patients with PD.


Subject(s)
Brain/pathology , Cognition Disorders/etiology , Cognition Disorders/pathology , Cognition , Parkinson Disease/diagnosis , Parkinson Disease/pathology , Aged , Brain/physiopathology , Cognition Disorders/physiopathology , Cohort Studies , Dementia/diagnosis , Dementia/physiopathology , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurologic Examination , Neuropsychological Tests , Parkinson Disease/complications
11.
Qual Life Res ; 19(8): 1097-103, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20443066

ABSTRACT

PURPOSE: This prospective study was performed to evaluate the effect of chemotherapy-related neurotoxicity on quality of life (QOL) of patients with lymphoma. METHODS: Thirty-two patients with diffuse large B-cell or follicular lymphoma without prior evidence of neuropathy were enrolled. Patients underwent the evaluations based on neuropathy symptom and disability score, nerve conduction studies, and SF-36 questionnaire for QOL assessment. They received six cycles of chemotherapy every three weeks, and all evaluations were repeated during and after the completion of 6th cycle. RESULTS: Sensory neuropathy-associated symptoms were observed in 27 patients (84.4%), and polyneuropathy was confirmed by nerve conduction study in 14 patients (43.8%). These patients with polyneuropathy showed worse QOL in domains mainly associated with physical health status including "physical function" compared to patients without polyneuropathy. There was a significant association of neuropathy symptom and disability scores with "bodily pain" and "vitality" of QOL domains. The serial evaluations of patients with neuropathy showed a worsening of QOL and neuropathy symptom scores during chemotherapy, then improvement of these values after chemotherapy. Thus, the final nerve conduction study confirmed the decrease in polyneuropathy compared to the 2nd evaluation (P = 0.032). CONCLUSION: Chemotherapy-related polyneuropathy may deteriorate QOL of patients with lymphoma, mainly physical health-associated QOL.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Lymphoma, B-Cell/drug therapy , Polyneuropathies/chemically induced , Polyneuropathies/complications , Quality of Life , Adult , Aged , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Female , Health Status , Humans , Lymphoma, Follicular/drug therapy , Lymphoma, Large B-Cell, Diffuse/drug therapy , Male , Middle Aged , Polyneuropathies/physiopathology , Prednisolone/administration & dosage , Prospective Studies , Rituximab , Severity of Illness Index , Vincristine/administration & dosage , Young Adult
12.
Clin Toxicol (Phila) ; 48(2): 149-52, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20050821

ABSTRACT

UNLABELLED: BACKGROUND, MATERIAL, AND METHODS: To assess plasma malondialdehyde (MDA) level as a clinical marker in acute paraquat (PQ) intoxication, we sequentially investigated 74 patients (40 males and 34 females, aged 49.9 +/- 16.2 years), all of whom ingested PQ as a means of suicide from July to December 2008. RESULTS: The baseline level of MDA (10.8 +/- 3.5 microM) had no correlation with plasma PQ levels of 22.1 +/- 48.7 microg/mL (median: 1.9, range <0.01-228.5) or with volume of PQ ingested. However, the following parameters were significantly different between survivors and nonsurvivors: the amount of PQ ingestion, plasma PQ levels, basal MDA levels, WBC, hemoglobin, hematocrit, platelet counts, albumin, BUN, creatinine, potassium, amylase, and arterial blood gas analysis (pH, pCO(2), HCO(-)(3)).The nonsurvivors' baseline MDA (11.4 +/- 3.8 vs. 9.8 +/- 2.8, p = 0.040) was higher than the survivors. However, the baseline level was not a predictor of mortality in the univariate and the multivariate binary logistic analyses. Among the patients whose MDA levels were measured sequentially, 58.3% of the patients (35 out of 60) showed fluctuating MDA levels, 25% (n = 15) showed steady decreases, with only 16.6% (n = 10) showing steady increases in MDA levels during the observation period. These findings imply the presence of active MDA metabolism and/or that the half-life of MDA is very short in the human body. CONCLUSION: Both cross-sectional and sequential measurements of plasma MDA do not provide reliable information on outcome in patients with acute PQ intoxication.


Subject(s)
Herbicides/poisoning , Malondialdehyde/blood , Paraquat/poisoning , Adult , Aged , Biomarkers/blood , Female , Half-Life , Herbicides/blood , Humans , Lipid Peroxidation/drug effects , Logistic Models , Male , Middle Aged , Multivariate Analysis , Paraquat/blood , Suicide , Suicide, Attempted
13.
Cerebrovasc Dis ; 28(6): 545-50, 2009.
Article in English | MEDLINE | ID: mdl-19844093

ABSTRACT

BACKGROUND: High-sensitivity C-reactive protein (hs-CRP) has been shown to be a powerful predictor of coronary ischemic events. However, the prognosis of functional disability in patients with cerebrovascular disease has not been well established. Therefore, we performed this study to determine the prognostic significance of hs-CRP levels in patients with functional disability after acute ischemic stroke. METHODS: A total of 417 Korean patients with ischemic stroke were examined within 24 h after symptom onset. hs-CRP measurements were obtained on admission and on the seventh hospital day. The correlations between the concentration of hs-CRP and functional disability duration 12 months after stroke onset were analyzed. RESULTS: The present study showed that hs-CRP levels on admission and on the seventh hospital day were significantly correlated with the modified Rankin Scale (mRS) score 12 months after stroke onset. These results also demonstrated that mRS scores are more closely associated with hs-CRP levels on the seventh hospital day than hs-CRP levels on admission. CONCLUSION: This study demonstrated that elevated hs-CRP levels on the seventh hospital day, rather than within 24 h after stroke onset, could strongly predict the prognosis of functional disability. These results supported that hs-CRP is a useful marker of ischemic stroke in the Korean population.


Subject(s)
C-Reactive Protein/metabolism , Disability Evaluation , Stroke/blood , Stroke/diagnosis , Aged , Biomarkers/blood , Female , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Prospective Studies , Republic of Korea , Retrospective Studies , Risk Factors , Stroke/ethnology
14.
Korean J Intern Med ; 24(3): 247-51, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19721862

ABSTRACT

BACKGROUND/AIMS: Paraquat (PQ) has been used in suicide attempts; an estimated 2,000 toxic ingestions occur annually, with 60-70% mortality. We sought to determine why PQ is such a common agent for suicide attempts in Korea. METHODS: We analyzed 250 cases (143 males, 107 females) of attempted suicide by PQ ingestion from January to December 2007. The procurement of the PQ was divided into two categories: purchased and preexisting. RESULTS: Men were more likely to have purchased PQ than women (66% vs. 22%, p=0.042). Additionally, men were more likely to be unmarried (n=34, 23.9% vs. n=10, 9.3%) or divorced or separated (n=16, 11.3% vs. n=5, 4.6%) than the women (p<0.001). The group who intentionally selected PQ (38.4%) consisted of 96 cases (54 males, 42 females) and the group who did not intentionally select PQ (61.6%) included 154 cases (89 males, 65 females). The incidence of PQ purchase was higher in the intentional selection PQ group (46.9% vs. 18.2%, p<0.01). CONCLUSIONS: Only 38% of patients who attempted suicide with PQ intentionally selected PQ. Thus, greater control of PQ availability is needed, especially in patients at risk.


Subject(s)
Herbicides/poisoning , Paraquat/poisoning , Suicide, Attempted , Adult , Female , Humans , Male , Middle Aged , Suicide, Attempted/psychology
15.
J Korean Med Sci ; 24 Suppl 2: S338-42, 2009 May.
Article in English | MEDLINE | ID: mdl-19503692

ABSTRACT

Quantifying and rating the impairments due to mental and behavior disorders are difficult for their own characteristics. Korean Academy of Medical Sciences (KAMS) is developing guidelines of rating impairment in mental and behavioral disorders based on Korean Neuropsychiatric Association (KNPA)'s new guidelines. We compared the new KNPA's guidelines and the American Medical Association (AMA)'s 6th Guides in assessing impairment due to mental and behavioral disorders to develop new guidelines of KAMS. Two guidelines are different in diagnosing system, applicable disorders, qualification of assessors, application of scales, contents of assessment and rate of impairment of the whole person. Both AMA's and the proposed guidelines have individual merits and characteristics. There is a limitation in using the 6th AMA's Guides in Korean situation. However to improve objectivity in Korean assessment of psychiatric impairment, the new AMA's Guides can serve as a good reference.


Subject(s)
Behavioral Symptoms/diagnosis , Disability Evaluation , Mental Disorders/diagnosis , Practice Guidelines as Topic , Academies and Institutes , Behavioral Symptoms/classification , Behavioral Symptoms/physiopathology , Brief Psychiatric Rating Scale/standards , Humans , Korea , Mental Disorders/classification , Mental Disorders/physiopathology , Program Development
16.
J Clin Neurosci ; 16(6): 807-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19297167

ABSTRACT

There have been few studies concerning osteoporosis in patients with Parkinson's disease (PD), even though patients with PD have a high incidence of falls. Using a Korean population, we investigated the association between bone mineral density (BMD) and PD. A total of 107 patients with PD were compared with age-matched and sex-matched normal controls. Using the Hoehn & Yahr staging system, we classified the patients with PD into three subgroups. Parts II and III of the Unified Parkinson's Disease Rating Scale were administered to evaluate the relationship between the severity of PD and BMD. In conclusion, in the PD population we found that decreased BMD was related to the severity of immobility of patients, and that BMD changes were greater at the femoral neck than the spine area. Therefore, we assert that clinicians should consider administering screening tests to elderly patients with PD and provide appropriate primary or secondary prophylactic treatment for osteoporosis.


Subject(s)
Bone Density/physiology , Bone and Bones/pathology , Osteoporosis/diagnosis , Osteoporosis/epidemiology , Parkinson Disease/epidemiology , Absorptiometry, Photon , Activities of Daily Living , Aged , Bone and Bones/diagnostic imaging , Bone and Bones/physiopathology , Cohort Studies , Comorbidity , Disability Evaluation , Female , Femur Neck/diagnostic imaging , Femur Neck/pathology , Femur Neck/physiopathology , Humans , Korea/epidemiology , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/pathology , Lumbar Vertebrae/physiopathology , Male , Middle Aged , Osteoporosis/physiopathology , Parkinson Disease/diagnosis , Parkinson Disease/physiopathology , Predictive Value of Tests , Prevalence , Prospective Studies , Sensitivity and Specificity , Severity of Illness Index
17.
J Neurol Sci ; 278(1-2): 60-3, 2009 Mar 15.
Article in English | MEDLINE | ID: mdl-19062047

ABSTRACT

Hyperhomocysteinemia is known to be an independent risk factor for arteriosclerosis. However, the prognosis of functional disability in cerebrovascular disease has not been well established. Therefore, we conducted this study to determine the prognostic significance of plasma homocysteine (Hcy) levels in Asian patients with functional disabilities after acute ischemic stroke. A total of 267 patients were examined within 24 h after symptom onset. Hcy was measured at admission. The correlations between plasma Hcy concentration and functional disability at 1-month, 3-months, 6-months, and 12-months after stroke onset were analyzed. In addition, the associations between each risk factor for stroke or neurological severity and plasma Hcy level were evaluated. The results of the present study showed that there was no significant correlation between Hcy level on admission and modified Rankin Scale score obtained at 1-month, 3-months, 6-months, and 12-months after stroke onset. There was also no association between plasma Hcy level and neurological severity after stroke or stroke subtype. This study showed that there is no association between Hcy levels and functional outcome after stroke. Therefore, we cautiously assert that plasma Hcy levels have no value as predictors of functional disability in Asian patients with stroke.


Subject(s)
Brain Ischemia/physiopathology , Homocysteine/blood , Stroke/physiopathology , Aged , Brain Ischemia/blood , Brain Ischemia/etiology , Female , Humans , Korea/epidemiology , Male , Models, Statistical , Neuropsychological Tests , Prognosis , Risk Factors , Stroke/blood , Stroke/etiology
18.
J Neurol Sci ; 273(1-2): 10-4, 2008 Oct 15.
Article in English | MEDLINE | ID: mdl-18602121

ABSTRACT

OBJECTIVES: The aims of this study were to obtain data on the frequency with which Korean patients with autoimmune myasthenia gravis (MG) present solely with ocular disturbances and progress to develop generalized disease and to identify the prognostic factors associated with secondary generalization. METHODS: We conducted a retrospective multicenter survey in which a total of 376 adult patients who were newly diagnosed with MG from 2000 through 2005 were reviewed for analysis. Patients with ocular MG at the time of symptom presentation (n=202, 53.7%) were divided into two subgroups according to their prognosis: the patients whose disease remained ocular throughout the follow-ups were placed in the OMG-R group, and the patients who progressed to develop generalized disease were placed in the OMG-G group. Clinical characteristics and laboratory findings were compared between the two subgroups. RESULTS: Secondary generalization developed in 47 (23.3%) of the 202 study subjects, mostly within the first 6 months after symptom presentation, while the disease remained ocular throughout the follow-up duration (median 11.8 months) in the remaining 155 patients (76.7%). AChR antibody, abnormal repetitive nerve stimulation tests (RNST) and thymoma were more frequently observed in the patients in the OMG-G group than in those in the OMG-R group (p<0.01 in all). In seropositive cases, the titers of AChR antibody were also significantly higher in the OMG-G group than in the OMG-R group (median, 3.8 nM vs. 6.4 nM; p<0.05). Cox proportional hazards regression analyses showed that early oral prednisolone treatment significantly reduced the risk of secondary generalization (HR, 0.24; 95% CI, 0.11-0.56), whereas abnormal AChR antibody (HR, 5.34; 95% CI, 1.60-17.8) and thymoma (HR, 2.32; 95% CI, 1.21-4.45) were predictive of the development of secondary generalization. CONCLUSIONS: Our findings suggest that several factors, including the AChR antibody, thymoma, early corticosteroid treatment, and possibly latent neuromuscular abnormality revealed by RNST, may have an impact on the risk of developing generalized disease in Korean patients presenting with ocular myasthenia.


Subject(s)
Aging/pathology , Myasthenia Gravis/diagnosis , Myasthenia Gravis/epidemiology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Female , Humans , Korea/epidemiology , Male , Middle Aged , Prognosis , Receptors, Cholinergic/immunology , Receptors, Cholinergic/physiology , Retrospective Studies , Statistics, Nonparametric
19.
Parkinsonism Relat Disord ; 14(7): 558-62, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18328767

ABSTRACT

Parkinson's disease (PD) may exhibit patterns of cognitive deficits, yet physicians are currently lacking operational criteria to define the clinical boundaries between PD and PD dementia (PDD). Therefore, we investigated the characteristics of the cognitive impairments in mild PDD. We recruited 30 PDD, 20 PD-MCI (PD with mild cognitive impairment without dementia) and 33 controls. All subjects were evaluated with detailed neuropsychological tests. Our results showed that visual memory, visuospatial functions, naming and calculation displayed more marked impairment than that of the other domains. Thus we suggest that adding cognitive dysfunctions of cortical type to the early cognitive deficits of PD-MCI can help predict the development of dementia.


Subject(s)
Cognition Disorders/diagnosis , Cognition Disorders/etiology , Dementia/complications , Neuropsychological Tests , Parkinson Disease/complications , Aged , Analysis of Variance , Attention/physiology , Case-Control Studies , Female , Humans , Male , Memory/physiology , Middle Aged , Problem Solving/physiology , Prospective Studies , Retrospective Studies , Space Perception/physiology
20.
J Clin Neurol ; 4(1): 23-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-19513320

ABSTRACT

BACKGROUND AND PURPOSE: Environmental factors might influence the pathogenesis of Parkinson's disease (PD) or multiple-system atrophy (MSA), and previous examinations of pesticide exposure, well-water drinking, and farming have produced inconclusive results. Because agriculture has been of considerable importance to Korean society, and hence the risk of exposure to pesticides was high in Korea, this study investigated whether such exposure is associated with elevated risks of developing PD and MSA. METHODS: Two hundred and thirty-five PD patients, 133 MSA patients, and 77 normal control subjects were examined. Data concerning environmental factors were collected by face-to-face interviews using a structured questionnaire. Odds ratios (ORs) were calculated by binary logistic regression. RESULTS: ORs for environmental risk factors for developing PD were 1.06 [95% confidence interval (CI) = 1.02-1.10] for age and 2.37 (95% CI = 1.32-4.27) for rural well-water drinking for >10 years. Smoking >10 pack-years (OR = 0.31; 95% CI = 0.11-0.64) was a preventable factor for developing PD in this study. However, no significant risk factors were identified for MSA. CONCLUSIONS: These results suggest that exposure to certain environmental risk factors plays a role in the development of PD. However, the development of MSA appears to be independent of environmental risk factors in Korean patients.

SELECTION OF CITATIONS
SEARCH DETAIL
...